113 related articles for article (PubMed ID: 11326644)
1. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer.
Lundin M; Nordling S; Carpelan-Holmstrom M; Louhimo J; Alfthan H; Stenman UH; Haglund C
Anticancer Res; 2000; 20(6D):4949-51. PubMed ID: 11326644
[TBL] [Abstract][Full Text] [Related]
2. Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer.
Louhimo J; Alfthan H; Stenman UH; Haglund C
Oncology; 2004; 66(2):126-31. PubMed ID: 15138364
[TBL] [Abstract][Full Text] [Related]
3. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma.
Hotakainen K; Ljungberg B; Paju A; Rasmuson T; Alfthan H; Stenman UH
Br J Cancer; 2002 Jan; 86(2):185-9. PubMed ID: 11870503
[TBL] [Abstract][Full Text] [Related]
4. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
[TBL] [Abstract][Full Text] [Related]
5. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
9. Tissue expression of human chorionic gonadotropin beta predicts outcome in colorectal cancer: a comparison with serum expression.
Lundin M; Nordling S; Lundin J; Alfthan H; Stenman UH; Haglund C
Int J Cancer; 2001 Jan; 95(1):18-22. PubMed ID: 11241305
[TBL] [Abstract][Full Text] [Related]
10. CNS germinoma with elevated serum human chorionic gonadotropin level: clinical characteristics and treatment outcome.
Ogino H; Shibamoto Y; Takanaka T; Suzuki K; Ishihara S; Yamada T; Sugie C; Nomoto Y; Mimura M
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):803-8. PubMed ID: 15936563
[TBL] [Abstract][Full Text] [Related]
11. Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers.
Legendre H; Decaestecker C; Nagy N; Hendlisz A; Schüring MP; Salmon I; Gabius HJ; Pector JC; Kiss R
Mod Pathol; 2003 May; 16(5):491-504. PubMed ID: 12748256
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of human chorionic gonadotropin beta and its association with survival in patients with colorectal cancer.
Birgisson H; Jirström K; Stenman UH
Cancer Biomark; 2012; 11(4):173-81. PubMed ID: 23144155
[TBL] [Abstract][Full Text] [Related]
13. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
[TBL] [Abstract][Full Text] [Related]
14. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
[TBL] [Abstract][Full Text] [Related]
15. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.
Birkenfeld S; Noiman G; Krispin M; Schwartz S; Zakut H
Eur J Surg Oncol; 1989 Apr; 15(2):103-8. PubMed ID: 2703054
[TBL] [Abstract][Full Text] [Related]
16. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma.
Chung YC; Chaen YL; Hsu CP
Anticancer Res; 2006; 26(5B):3905-11. PubMed ID: 17094421
[TBL] [Abstract][Full Text] [Related]
19. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C
J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
